INSIDE INFORMATION
REGULATED INFORMATION
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
[...] Read more »Nyxoah Reports Third Quarter 2025 Financial and Operating Results
REGULATED INFORMATION
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
US launch off to a strong start. First commercial Genio [...] Read more »
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
REGULATED INFORMATION
Nyxoah Reports Third Quarter 2025 Financial and Operating Results
US launch off to a strong start. First commercial Genio [...] Read more »
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Troisième Trimestre 2025
INFORMATIONS RÉGLEMENTÉES
Nyxoah Présente ses Résultats Financiers et d’Exploitation
pour le Troisième Trimestre [...] Read more »
شركة Profound Medical توقع اتفاقية توزيع حصرية لمنتجات TULSA-PRO®وSonalleve® مع شركة Al Faisaliah Medical Systems في المملكة العربية السعودية
الاتفاقية تفتح المجال أمام علاجات [...] Read more »
NeOnc Technologies Reports Updated Clinical Results
CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical–stage biopharmaceutical company [...] Read more »
Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
Agreement creates runway for Profound’s incision–free and radiation–free therapies for the ablation of diseased tissue, to penetrate the largest healthcare market in the Middle East
Read more »
Namib Minerals – Production and Operational Update
HARARE, Zimbabwe, Nov. 10, 2025 (GLOBE NEWSWIRE) — Namib Minerals (Nasdaq: NAMM) (“Namib Minerals” or the “Company”) today provided an operational update, including production guidance for 2025 [...] Read more »
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
CALABASAS, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a clinical–stage biopharmaceutical company [...] Read more »
WeRide Lists on Hong Kong Stock Exchange, Becoming World's First Publicly Traded Robotaxi Company in Hong Kong and US
HONG KONG, Nov. 06, 2025 (GLOBE NEWSWIRE) — WeRide (HKEX: 0800.HK, NASDAQ: WRD), a global leader in autonomous driving technology, today announced its successful listing on the Stock Exchange [...] Read more »